Our story
Anti-glycation skincare powered by Supplamine®, developed by a scientist and dispensed by physicians.
It began in the lab
MEG 21 was developed by Dr. Annette Tobia, PhD, from glycation research pioneered at Fox Chase Cancer Center.
The research began with diabetes-related glycation. Dr. Tobia saw what it could mean for skin, and brought it to skincare.
Developed by Dr. Annette Tobia, PhD. Dispensed by physicians.
Glycation, simply put
The science behind MEG 21.
Sugars meet proteins
Natural sugars bind to the collagen and elastin in skin. This is called glycation.
It shows on skin
Over time, skin can look duller, less firm and more lined.
Supplamine® at the core
Our signature complex, designed to help skin look firmer, smoother and more even.
What stands behind MEG 21
Published research
A published randomized controlled trial and eight clinical studies, all on human subjects.
Patented technology
The Supplamine® technology is patented.
Physician-dispensed
Recommended and dispensed in physician practices and med spas.
Made in the USA
Every MEG 21 formula is made in the United States.
Our mission
To bring advanced, clinically backed science into everyday skincare, with formulas that help skin look firmer, smoother and more radiant, recommended by the physicians you trust.
Try MEG 21 with the Discovery Kit
Five travel sizes of the MEG 21 anti-glycation range in a custom cosmetic bag: the serum, two treatments, the eye treatment and the mineral SPF. The whole routine, before you commit to full sizes.
Shop the Discovery Kit — $30